Skip to main content
OpenTrials

Clinical trial condition

Esophageal Cancer

Explore clinical trials studying Esophageal Cancer. Study availability and eligibility vary by location and protocol.

720 public trials 179 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Cancer trial results

Completed

Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer

NCT00217581

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States
  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

FLOTOR Pilot Study

NCT03292757

Conditions
Chylothorax, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Department of Upper GI Surgery, Oxford University Hospitals Headington, Oxfordshire, United Kingdom
View Trial Details
Completed

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +53 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Avastin and Taxotere for Esophagogastric Cancer

NCT00137813

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +10 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions